Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7504008 | Drug and Alcohol Dependence | 2016 | 9 Pages |
Abstract
These data confirm that intranasal buprenorphine/naloxone has deterrent properties related to transient withdrawal effects that likely decrease its desirability for misuse compared to buprenorphine in opioid-dependent individuals maintained on short-acting opioids.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Sharon L. Walsh, Paul A. Nuzzo, Shanna Babalonis, Victoria Casselton, Michelle R. Lofwall,